Aimovig 70 mg/ml, Injektionslösung im Fertigpen

7680667480020 CH-66748 Injektionslösung im Fertigpen
Aimovig 70 mg/ml, Injektionslösung im Fertigpen
Aimovig 70 mg/ml, Injektionslösung im Fertigpen
Aimovig 70 mg/ml, Injektionslösung im Fertigpen
1 / 3
google

Article details

Package size
1 x 1 ml
Selling units
1
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Injektionslösung im Fertigpen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/11/2022
Patient information leaflet
Français
04/11/2022
Patient information leaflet
Italien
04/11/2022
Summary of Product Characteristics
Allemand
04/11/2022
Summary of Product Characteristics
Français
04/11/2022
Summary of Product Characteristics
Italien
04/11/2022

Detailed composition

Substance Quantity Type Category
(N/A)
70.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.2 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 437.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2018

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
66748
Drug name
Aimovig, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
N02CD01
Authorization status
Z
Dispensing category
B
First authorization
13/07/2018
Authorization expiration date
31/12/9999
IT Number
02.05.1.
Domain
Human medicine
Field of application
Migräneprophylaxe

Package details

Description (FR)
AIMOVIG sol inj 70 mg/ml stylo pré-remp 1 ml
Description (DE)
AIMOVIG Inj Lös 70 mg/ml Fertigpen 1 ml
Market launch
13/07/2018
Narcotic (BTM)
No

Other package sizes (2)

None
None None
GTIN: None
Not in V1
AIMOVIG sol inj 140 mg/ml stylo pré-rempli 1 ml
1 x 1 ml INJ
GTIN: 7680667480037
View